Breast cancer is one of the most common types of cancer in the UK. Most people diagnosed with breast cancer…

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate…

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared…

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely…

The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the…

Global, Phase 3, randomized, multicenter, open-label study evaluating the efficacy and safety of firmonertinib at a dose level of 240…

Multicenter, randomized, controlled, open-label, Phase 3 study designed to demonstrate that neladalkib (NVL-655) is superior to alectinib in prolonging progression-free…

Researchers are looking for new ways to treat people with extensive-stage small cell lung cancer (SCLC) that has relapsed or…

Cancer is one of the leading causes of mortality worldwide and is responsible for an estimated 9.6 million deaths yearly.…

The aim of Neo-POLEM is to determine the rate of Major Pathological Response (MPR) of